|Year : 2015 | Volume
| Issue : 4 | Page : 286-294
A surveillance model for sexually transmitted infections in India
Partha Haldar1, Guy Morineau2, Anjana Das3, Sanjay Mehendale4
1 Assistant Professor, Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
2 Surveillance and Research Advisor, Asia Pacific Regional Office, Bangkok, Thailand
3 Director STI, FHI 360, New Delhi, India
4 Director, National Institute of Epidemiology, Chennai, Tamil Nadu, India
|Date of Web Publication||17-Nov-2015|
Assistant Professor, Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi - 110 029
Source of Support: None, Conflict of Interest: None
| Abstract|| |
The strategy for prevention and control of sexually transmitted infections (STIs) in India is based on syndromic case management delivered through designated STI/reproductive tract infection (RTI) centers (DSRCs) situated in medical colleges, district hospitals, and STI-clinics of targeted interventions programs. Laboratory tests for enhanced syndromic management are available at some sites. To ensure country-level planning and effective local implementation of STI services, reliable and consistent epidemiologic information is required on the distribution of STI cases, rate and trends of newly acquired infections, and STI prevalence in specific population groups. The present STI management information system is inadequate to meet these requirements because it is based on syndromic data and limited laboratory investigations on STIs reported passively by DSRCs and laboratories. Geographically representative information on the etiology of STI syndromes and antimicrobial susceptibility of STI pathogens although essential for optimizing available treatment options, is deficient. Surveillance must provide high quality information on: (a) prevalence of STIs such as syphilis, trichomoniasis, gonorrhea, and chlamydia among high-risk groups; syphilis in the general population and pregnant antenatal women; (b) demographic characteristics such as age, sex, new/recurrent episode, and type of syndromically diagnosed STI cases; (c) proportion of acute infections such as urethral discharge (UD) in men and nonherpetic genital ulcer disease (GUD) in men and women; (d) etiology of STI syndromes; and (e) gonococcal antimicrobial susceptibility. We describe here a framework for an STI sentinel surveillance system in India, building on the existing STI reporting systems and infrastructure, an overview of the components of the proposed surveillance system, and operational challenges in its implementation.
Keywords: Framework, India, sentinel surveillance, sexually transmitted disease (STD), sexually transmitted infection (STI)
|How to cite this article:|
Haldar P, Morineau G, Das A, Mehendale S. A surveillance model for sexually transmitted infections in India. Indian J Public Health 2015;59:286-94
|How to cite this URL:|
Haldar P, Morineau G, Das A, Mehendale S. A surveillance model for sexually transmitted infections in India. Indian J Public Health [serial online] 2015 [cited 2021 Dec 2];59:286-94. Available from: https://www.ijph.in/text.asp?2015/59/4/286/169658
| Introduction|| |
Surveillance denotes ongoing systematic collection, collation, analysis, and interpretation of output and outcome-specific data for the planning, implementation, evaluation, and improvement of public health practice.  The success of a surveillance system depends on timely dissemination of derived information to policymakers and program implementers to develop and implement evidence-based effective interventions.  Surveillance systems can provide information about time, place, and person distribution of all cases of disease diagnosed in any setting (universal surveillance) or from a sample thought to provide services for populations at high risk of disease (sentinel surveillance). 
Why sexually transmitted infection surveillance?
Annually, as per the estimates of the World Health Organization (WHO) 498.9 million curable sexually transmitted infections (STIs) occur globally.  Studies suggest that the population prevalence of STIs such as syphilis, gonorrhea, and chlamydia has a range of 0-3.9% in India but the STI burden is much higher among subpopulations practicing high-risk behavior.  An efficient program management for STIs requires reliable and consistent information on the level and trends of recently acquired STI and prevalence of STI in different population groups that are at a higher risk of acquiring STI. Additionally, a good understanding of the etiological profile of the syndromes and patterns of antimicrobial susceptibility form the basis for updating STI treatment guidelines periodically.
International experience with surveillance for sexually transmitted infections
Various forms of surveillance strategies for STIs are practiced globally. Universal etiological case reporting in the United States of America captures all the diagnosed STI cases.  In European countries such as Germany, France, and the United Kingdom, and KwaZulu Natal in South Africa, the STI surveillance system involves private practitioners and private laboratories. ,, In China, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), syphilis, and gonorrhea are reportable STIs to the national surveillance system by law  although data are also collected on chlamydia, condylomata acuminata, and herpes simplex virus (HSV) infection.  In Brazil, epidemiological data on STIs are scarce but notification is mandatory for HIV/AIDS in pregnant women and exposed children as well as syphilis and urethral discharge syndrome in men.  Thailand has a robust universal etiological STI surveillance system, which is actively used for program planning. 
Description of STI reporting system of National AIDS Control Organization (NACO) in India
At present, the National AIDS control program of India (NACP) implemented by NACO collects service statistics on STI syndromes and syphilis screening among STI and antenatal clinic attendees through the computerized management information system (CMIS). The reporting units include designated STI/RTI clinics (DSRCs) and STI clinics of targeted interventions (TIs). The latter provides on-site services to high-risk groups such as men who have sex with men (MSM), female sex workers (FSWs), injecting drug users (IDU), transgenders, long-distance truckers, and male migrants.  Between 2007 and 2012, 34.9 million (range 2.6-10 million per year) episodes of STI and RTI have been treated at the STI clinics managed by NACO.  In addition, seven regional STI training, reference, and research centers provide information on etiologic diagnoses and gonococcal antimicrobial susceptibility. Recently, NACO has also initiated reporting of STI syndromes at subdistrict levels through the Health Management Information System (HMIS) of the National Rural Health Mission (NRHM).
Strengths and limitations of the existing National AIDS Control Organization surveillance mechanism and infrastructure
There are challenges in interpreting information on STI that emerge from the service facilities due to incompleteness and/or inconsistent reporting. The information are a mix of syndromic and etiologic case reporting.  There is nonuniformity in data due to suboptimal adherence to NACO's STI syndromic case definitions and national guidelines for data collection and reporting mechanisms by the staff responsible for data collection and reporting. Additionally inadequate syphilis posttest reporting and follow-up and operational problems such as the lack of explicit guidelines for reporting STI cases attending other departments (most importantly those attending the outpatient gynecology department also contribute to incompleteness of reported data. The present STI reporting system is restricted to symptomatic cases who attend health care facilities.  Thus, information on asymptomatic infections particularly among women are not captured. Similarly, symptomatic patients seeking care at facilities other than the government clinics or alternative systems of medicine also remain unreported. Data derived from STI prevalence studies show wide variations in methodology for laboratory diagnosis, clinic based risk-group investigations, and geographical areas. 
Initiating "sentinel" surveillance for sexually transmitted infection in India
For various reasons mentioned above, India needs a STI sentinel surveillance system that is accurate, adequate, and uniform and hence, should include a limited number of purposively selected sites and population groups. The "sentinel" nature would help ensure greater supervisory support and regular monitoring to maintain a high level of data quality that is strikingly deficient in the present system. , Additional in-depth qualitative information on few key risk behaviors could also be collected from a subsample. The data on prevalence and syndromic etiology obtained from the sentinel surveillance system should be used in conjunction with the management information system (MIS) data to describe the national burden of STI. , It is essential that syndromic approach, which is the mainstay of STI case management in India, is validated regularly. Sentinel STI surveillance system would provide a good platform for this purpose. Systematically and timely collected accurate and detailed STI surveillance data from different population groups and geographical areas are needed to monitor the trends in incidence, prevalence, STI etiology, antimicrobial susceptibility, and risk behaviors of STI among different population subgroups and to decide on treatment guidelines. This would help to appropriately plan resources and improve patient management. This article suggests a framework for STI surveillance in India that will build on the STI reporting systems and infrastructure that are already in place.
| Methods|| |
The following core components are being proposed to achieve the abovementioned objectives. The rationale for each of the core components is summarized in [Table 1].
|Table 1: Gap analysis of the present surveillance system for STI in India|
Click here to view
Core component #1: To estimate the magnitude of sexually transmitted infection syndromes and to estimate the proportion of new infections
Inferential and analytical strengths of syndromic diagnosis will be provided by supplementing this data with demographic details on age, sex, and place of residence. The presenting syndrome will be characterized as a new or recurrent episode. The STI program in India partly collects and reports some findings based on elements captured through 1,100 STI  reporting units. Information on STI syndromes would help monitor the distribution of STI disaggregated by age group, sex, geographical area (place of residence), etc. Additionally, data on the number of attendees at a clinic would be helpful in planning appropriate treatment and follow-up services based on estimated STI disease burden at the clinic.
An estimate of newly acquired infections will be derived from acutely presenting syndromes. These include urethral discharge (UD) in men and nonherpetic genital ulcer disease (GUD) among men and women.  STI surveillance is a component of second generation HIV surveillance.  STIs are considered as markers of unprotected sexual intercourse and ongoing high-risk sexual activity. Hence, surveillance for newly acquired STI will potentially provide warning signals for HIV transmission through the sexual route. This information will be especially useful in low HIV prevalence areas to monitor HIV transmission. 
Core component #2: To assess specific etiologies for presenting syndromes periodically
The etiologies of syndromes will be determined to estimate the burden of specific pathogens and to update treatment guidelines to update treatment guidelines. The etiologies of common syndromes such as UD among men, GUD among men and women and vaginal discharge among women will be assessed every 2-3 years. A recent study from India assessed the etiologies among men with complaints of genital ulcer; based on high detection rates for Treponema Pallidum, the study suggested a revision of existing national STI treatment guidelines in India to include treatment of syphilis for all GUD patients.  Thus, periodic monitoring for the changing spectrum of etiologies would guide STI syndromic treatment.
Core component #3: To determine prevalence of sexually transmitted infections in different population groups and identify their demographic determinants
Cross-sectional surveys will be conducted to monitor STI prevalence in both the general population and among subgroups that are at a higher risk of acquiring STI. STI control programs need prevalence data to monitor their trends and to understand which population groups are at a greater risk for infection. These prevalence surveys would determine what percentage of people has STI. Over the years, this would enable observing prevalence trends to assess the efficacy of interventions. Prevalence data are required for estimating the burden of STI, prioritizing funding and resource allocation, identifying population groups at high risk of HIV, and helping to monitor the effectiveness of prevention programs for HIV/STI. Various population categories such as sexually active groups (FSW and MSM), pregnant women, and family planning clinic attendees are to be assessed for syphilis, trichomoniasis, gonorrhea, and chlamydia. Recruitment of subjects for such surveys can be done at sentinel sites that could be either facility based such as antenatal and family planning clinics or drop-in centers at a TI site [for high-risk group (HRG) populations]. With appropriate operational adjustments, these surveys can also be combined, along with bio-behavioral surveys or HIV sentinel surveillance.
Core component #4: To determine antimicrobial susceptibility
Optimum treatment of Neissseria gonorrhoeae (NG) infection is necessary to achieve microbiological cure, along with a relief of the signs and symptoms of infection and prevention of serious complications. Emerging antibiotic resistant strains of NG is a worldwide concern. Decreased susceptibility of NG to tetracycline was reported as early as 1971 from India.  Recently, resistance to oral third-generation cephalosporins such as cefixime and ceftibuten has been reported from Japan, Hong Kong, and Taiwan.  In view of the elevated minimum inhibitory concentrations (MICs) for cefixime, the Centers for Disease Control and Prevention (CDC) 2010 treatment guidelines does not recommend cefixime as a first-line regimen for treatment of gonococcal infections.  Thus, monitoring of antibiotic resistance pattern against NG is a core component of STI surveillance activity that would provide necessary information for the optimization of treatment regimens. Majority of the studies on antimicrobial resistance for gonorrhea in India have been conducted at tertiary referral care centers, mostly from Northern India.  Therefore, to determine the extent and distribution of antimicrobial susceptibility to common antibiotics used in the treatment of STI in the country, testing will be done periodically in different geographical areas.
STI sentinel surveillance mechanism
What should be the sentinel units?
Given the heterogeneity in the country, we propose to consider a district as a sentinel unit, within which selected (sentinel) DSRCs, TIs, and (if present) private practitioner clinics would function as sentinel reporting sites. Initially, a convenience sample of the desired number of districts with a large population of HRGs, high-risk behavior of key population groups, documented high prevalence of STI, and evidence of substantial population migration will be selected. To enable etiological diagnosis, availability of specimen transport facilities and access to laboratories would also be considered.
The basic platform for the surveillance system will consist of STI or gynecology clinics, TI clinics, or private STI clinics. The selection of TI clinics would be a purposive sampling dependent upon their performance, ability to handle data management, possession of data quality practices, and the willingness to participate in such a surveillance system. A presurveillance feasibility assessment of the sentinel reporting sites will be made for the assessment of client turnover, presence of essential infrastructure, and willingness of staff and laboratory facilities (at places where etiological tests would be performed).
Types of surveillance
Syndromic core surveillance will be carried out routinely and all through the year to track the burden and trends of various syndromes, whereas etiological surveillance for STI will be periodically attempted with strong laboratory testing support to track the transmission patterns of STI pathogens. Prevalence surveys will be conducted among specific population groups in these districts. For conservation of resources, the possibility of combining STI prevalence surveys with HIV bio-behavioral surveys will be explored.
The sentinel populations
There is a need to capture STI data from different population groups, namely, populations with high-risk behaviors, bridge populations, and the general population.  We have already proposed that sexually active groups (FSW and MSM), pregnant women, and family planning clinic attendees could be the populations initially targeted for inclusion in sentinel surveillance. Standard case definitions (based on syndromic or etiologic diagnosis) will be used [Table 2]. For etiological diagnosis, the infrastructure of STI laboratory facilities set up by NACO should be utilized. This includes the seven regional STD laboratories (RSLs) and the state reference centers (SRCs). The SRCs would perform the first-level tests and store the samples, which would be shipped periodically to the RSLs for evaluation and validation of results. The RSLs would be responsible for training, quality assurance and the management of the SRCs.
Sampling and sample size
The routine core surveillance will cover all the clinic attendees but care will be taken to ensure that no participant is included in the survey for more than once every year. The sample size for etiological survey would depend on the specific etiology and its anticipated prevalence. However, a minimum sample size of 100 specimens from consecutive patients with the specified syndrome will provide preliminary information for analysis.  Consecutive sampling may be considered as a type of systematic random sampling where the sampling interval is zero. For the antimicrobial susceptibility surveys, a sample size of around 100 is targeted.  Swabs would be collected from consecutive men and women presenting with a visible urethral discharge and cervical discharge, respectively.
Computerized data management for surveillance for STIs would greatly help in automated data transfer, data validation, and timely customized report generation. Data should therefore, be entered in standard data formats at the source, in software capable of handling multilevel entries and validation.
Training and support activities
The operational guidelines, training manuals, and job-aids will be developed for providing guidance on case definitions for syndromes/etiologies to be reported; the roles and responsibilities of the staff; steps for data entry and troubleshooting; eligibility criteria, steps for specimen collection for prevalence surveys; standard operating procedures (SOPs) for laboratory procedures, etc. Surveillance output would be dependent on the quality of training of the surveillance staff. To ensure uniform standards across sentinel sites, modular training using a standardized training manual will be utilized.
Such a large scale activity would require the presence of a coordination team that would contribute to the finalization of surveillance design, selection of the sentinel units, meeting regularly to review progress, and the addressing of challenges. The regional centers for STIs, being the centers of excellence, may be imparted regional responsibility for periodic presurveillance assessment of sentinel reporting units, trainings for surveillance, monitoring, supervision, quality control, data entry, data analyses, coordination between sentinel districts and the central nodal agency, and regional trouble shooting.
Monitoring will assess the adequacy of sentinel clinic infrastructure for data and sample collection; presence of trained staff (medical officer, laboratory technician); adherence to surveillance protocol, measures of confidentiality, guidelines for sample collection and processing; presence of adequate laboratory as well as nonlaboratory consumables and checks for data quality using a specially developed and uniformly adopted checklist.
Stigma and the resultant discrimination of the people who have STI has been one of the reasons for the lack of complete and reliable STI/RTI data in India.  Confidentiality of client information will be preserved by the delinking of personal identifiers, development of appropriate guidelines, and training of clinic/laboratory staff involved in surveillance. A decision to communicate to the client the results of antimicrobial susceptibility tests, otherwise valid only at the population level, would depend upon assessing the benefits for the management of individual patients.
| Results and Discussion|| |
The objectives of this paper was to propose a framework for STI surveillance in India so as to improve STI program planning and management by estimating the magnitude of STI syndromes, deciding the etiology, describing the distribution in different subpopulations and geographical areas by various population characteristics, and monitoring the trends over time. It will also contribute in ensuring a uniform reporting of STI syndromes and improving patient care by suggesting appropriate treatment algorithms for common STI syndromes based on the observed antimicrobial susceptibility patterns.
It is anticipated that with serious emphasis on establishing the STI sentinel surveillance, giving adequate emphasis on quality management at high levels, this network will be able to meet its objectives. STI case reporting will be etiologic as well as syndromic. Data should be analyzed at each stratum (district, state, and national) for enabling appropriate programmatic actions [Table 2]. Increase, decrease, or other unusual findings will have to be adequately investigated.
Simplicity, timeliness, and data quality will be the most essential attributes of the STI sentinel surveillance program. No new data variable is being proposed. While syndromic reporting is proposed to be a regular feature (monthly reporting as is being done currently), etiological reporting if conducted once in 2 years will suffice. Additional effort would be only in terms of computing individual case based data entry so as to enable cross-tabulation of diagnoses with other variables. Data forms for private practitioners should be simple, straight-forward, and with minimum variables to be reported. Simplicity of data forms, standardized and uniform training, and regular supervision would help to ensure quality of the reported data. Sensitivity and representativeness: Sensitivity of a surveillance system can be defined either as the proportion of cases detected by the surveillance out of all who are infected or by the completeness of case-reporting. Sensitivity could be affected by the probability that a person with STI seeks care at a health facility, which is a sentinel site; the syndrome is correctly diagnosed by the physician (physician skill-dependent upon training) or the etiology is correctly picked up by the laboratory test (depends upon various laboratory factors); the STI syndrome/etiology is reported after the diagnosis is made (responsibility of the clinic counselor or laboratory technician for reporting dependent upon training). According to the model we propose, all DSRCs in the sentinel district would report the syndromes diagnosed. Assuming that reported cases are correctly diagnosed, (i.e., there is no misclassification), this model is expected to pick the proportion of STI cases who would be reporting to government health care facilities. As per the national Behaviour Surveillance Survey (BSS) among the general population, self-reported health care seeking for STI symptoms was 25.7% for government facilities (43.6% did not seek any care).  Hence, by involving high turnover private practitioners to the reporting network as per our model, this proportion would be higher. Around 29% of the general population respondents in the BSS 2006 had reported preferring a private practitioner for a future episode of STI. 
A detailed plan of dissemination should include the steps, timeline, and people identified for performing quality checks, data validation, preparation of data tables, making the data available for data analysis, analysis of the data, interpretation of the findings, preparation of customized reports for national, state, district, and sentinel site/clinic levels, and its systematic dissemination. Targeted training of the hierarchy of the staff identified should be a prerequisite. End-user experience of STI surveillance information could be enhanced by representing spatial relation between risk factor/demographics and outcome of interest such as case distribution mapping. 
| Conclusion|| |
We have described the framework to initiate a surveillance system for STI in India where STIs have been recognized as a major public health problem. In a resource-limited setting, a mixed approach of passive and active surveillances is more appropriate because a newly initiated surveillance system would take time to get established, reach adequate coverage levels, and be able to generate consistent and reliable data. Hence, efforts should continue to strengthen the current routinely and passively collected STI information. Reliable data on the core components of STI surveillance would enable measuring the success of these important efforts and would assist program managers in evidence-based future planning. We have not attempted an economic evaluation of the proposed surveillance system. However, if the proposed model is considered to have scientific merit, financial implications of its implementation may be carefully considered.
This work was supported by the Bill and Melinda Gates Foundation, grant number OPP31280, through FHI360, Country Office, India. The views expressed herein are those of the authors, and do not necessarily reflect the official policy or position of the Bill and Melinda Gates Foundation, or that of FHI360.
Financial support and sponsorship
This work was supported by the Bill and Melinda Gates Foundation, Grant Number OPP31280, through FHI360, Country Office, India that supported consultancy fees of the first author, as an FHI360 Consultant in year 2012-2013.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Thacker SB, Berkelman RL. Public Health Surveillance in the United States. Epidemiol Rev 1988;10:164-90.
Teutsch SM, Churchill RE. Principles and Practices of Public Health Surveillance. 2 nd
ed. New York: Oxford University Press; 2000. p. 1.
Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol 1994;140:383-97.
World Health Organization (WHO). STI Estimates Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008. Geneva: World Health Organization; 2008. p. 2.
Report on Mid-Term Review of Sexually Transmitted Infections Services; National AIDS Control Programme Phase-III. New Delhi: National AIDS Control Organization India, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2009. p. 11.
CDC - STD Surveillance, 2010. Available from: http://www.cdc.gov/std/stats10/default.htm. [Last accessed on 2013 Mar 21].
Bremer V, Marcus U, Hofmann A, Hamouda O. Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003. Sex Transm Infect 2005;81:173-9.
Ihekweazu C, Maxwell N, Organ S, Oliver I. Is STI surveillance in England meeting the requirements of the 21 st
century? An evaluation of data from the South West Region. Euro Surveill 2007;12:E9-10.
Wilkinson D, Connolly AM, Harrison A, Lurie M, Karim SS. Sexually transmitted disease syndromes in rural South Africa. Results from health facility surveillance. Sex Transm Dis 1998;25:20-3.
Chen XS, Peeling RW, Yin YP, Mabey DC. The epidemic of sexually transmitted infections in China: Implications for control and future perspectives. BMC Med 2011;9:111.
Pearline RV, Tucker JD, Yuan LF, Bu J, Yin YP, Chen XS, et al
. Sexually transmitted infections among individuals over fifty years of age in China. AIDS Patient Care STDS 2010;24:345-7.
Cavalcante EG, Araújo MA, Galvão MT, de Moura HJ, Gondim AP, da Silva RM. Sexually transmitted infections associated syndromes assisted in the primary health care in Northeast, Brazil. BMC Public Health 2012;12:595.
Leenuwongphun C. STIs Surveillance in Thailand. Personal Communication. Program Manager of AIDS and STD. 2012.
Operational Manual on Strategic Information on Management Unit. New Delhi: National AIDS Control Organization India, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2007.
Annual Report 2011-12. New Delhi: National AIDS Control Organization India, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2012. p. 17.
Technical Consultation to Review HIV Surveillance in India. New Delhi: World Health Organization, Regional Office for South-East Asia; 2008. Available from: http://www.searo.who.int/LinkFiles/Publications_HIV_Tech_Consul.pdf. [Last accessed on 2012 Oct 31].
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for Second Generation HIV Surveillance: An Update: Know your Epidemic. Geneva: World Health Organization; 2011. p. 11.
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for Second Generation HIV surveillance. Geneva: World Health Organization; 2000. p. 18.
Redefining AIDS in Asia - Report of the Commission on AIDS in Asia. New Delhi: Oxford University Press; 2008.
Prabhakar P, Narayanan P, Deshpande GR, Das A, Neilsen G, Mehendale S, et al
. Genital ulcer disease in India: Etiologies and performance of current syndrome guidelines. Sex Transm Dis 2012;39:906-10.
Moses JM, Desai MS, Bhosle CB, Trasi MS. Present pattern of antibiotic sensitivity of gonococcal strains isolated in Bombay. Br J Vener Dis 1971;47:273-8.
Bala M. Characterization of profile of multidrug-resistant Neisseria gonorrhoeae using old and new definitions in India over a decade: 2000-2009. Sex Transm Dis 2011;38:1056-8.
Centers for Disease Control and Prevention (CDC). Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012;61:590-4.
Behaviour Surveillance Survey among General Population. New Delhi: National AIDS Control Organization India, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2006.
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Strategies and Laboratory Methods for Strengthening Surveillance of Sexually Transmitted Infection 2012. Geneva: World Health Organization; 2012. p. 43.
Ray K, Bala M, Bhattacharya M, Muralidhar S, Kumari M, Salhan S. Prevalence of RTI/STI agents and HIV infection in symptomatic and asymptomatic women attending peripheral health set-ups in Delhi, India. Epidemiol Infect 2008;136:1432-40.
Scribner RA, Cohen DA, Farley TA. A geographic relation between alcohol availability and gonorrhea rates. Sex Transm Dis 1998;25:544-8.
[Table 1], [Table 2]